Alcon Inc. Ordinary Shares

Financials

영업활동으로 인한 현금 823 M1.34 B1.22 B1.39 B2.08 B2.27 B — 투자 활동으로 인한 현금 572 M1.2 B1.86 B1.09 B1.17 B1.34 B — 재무활동으로 인한 현금 466 M123 M8 M211 M322 M1.12 B — 잉여 현금 흐름 823 M1.34 B1.22 B1.39 B2.08 B2.27 B —

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

ALC

Financials

Alcon Inc. Ordinary Shares

뉴스

Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?

Reasons to Retain STE Stock in Your Portfolio for Now

EYE Q1 Earnings & Revenues Beat Estimates, Operating Margin Expands

PBH Q4 Earnings & Revenues Miss Estimates, Margins Down

STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading

HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut

조에티스·인스메드·허브스팟 등 지난주 최대 급락한 대형주 10종목 (5월 4일~8일)

GMED Stock Rises on Q1 Earnings & Revenue Beat, '26 EPS View Raised

Here's Why Alcon (ALC) is a Strong Value Stock

ALC vs. PEN: Which Stock Should Value Investors Buy Now?

ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth

ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth